Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients (Q43040687)
Jump to navigation
Jump to search
scientific article published on 23 October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients |
scientific article published on 23 October 2002 |
Statements
1 reference
Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients (English)
1 reference
Shelley F Stone
1 reference
Silvia Lee
1 reference
Niamh M Keane
1 reference
Patricia Price
1 reference
23 October 2002
1 reference
1 reference
Identifiers
1 reference